BMO Capital downgraded Omega Healthcare (OHI) to Market Perform from Outperform with an unchanged price target of $45. BMO adjusted real estate investment trust ratings as part of its 2026 outlook. The firm sees limited upside to Omega’s 2026 guidance and recommends taking profits at current share levels.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OHI:
- Omega Healthcare price target raised to $51 from $50 at UBS
- Omega Healthcare Amends Executive Contracts, Enhances Severance Terms
- Omega Healthcare price target raised to $45 from $43 at Jefferies
- Omega Healthcare price target raised to $46 from $44 at Truist
- Omega Healthcare price target raised to $48 from $45 at Wells Fargo